Build a Heart. Save a life.
BIOLIFE4D is committed to perfecting the technology to make viable organ replacement a safe, accessible and affordable reality. With BIOLIFE4D, a patient-specific, fully functioning heart will be created through 3D bioprinting and the patient’s own cells, eliminating the challenges of organ rejection and long donor waiting lists that plague existing organ transplant methods.

BUILD A HEART SAVE A LIFE

IMPORTANT Investor Update – 12/8/18

Effective January 31st, 2019 we will no longer be accepting investments through our equity crowdfunding offering.

Until then you can still contact us directly at 224-602-9569 and we will personally assist you in the investment process, whether it is making an initial investment or increasing your current equity position in BIOLIFE4D.

TIME IS RUNNING OUT, our stock purchase price has already risen 20% from $10 to $12 a share since our campaign began in February and your time to participate and become a shareholder will end shortly.
 

Bioprinter layering bio-ink of human heart cells
BIOPRINTING
What if we could print a human heart? Science has found a way. This is not science fiction. This is science fact. This is BIOLIFE4D.

Learn More See Bioprinting in Action

Heart cell for 3D bioprinting
BIOLIFE4D PROCESS
It starts with a patient’s own cells and ends with a bioprinted heart that’s both a precise fit and perfect genetic match.

Learn More

Heart cell for 3D bioprinting
BIOLIFE4D logo
INVEST
BIOLIFE4D is now open for investors to purchase stock and participate in the development of this remarkable new process.
Invest Now Learn More

BIOLIFE4D in the News!

By Emilia Benton, Correspondent  Updated 10:11 am CDT, Tuesday, October 23, 2018 According to U.S. Government Information on Organ Donation and Transplantation, hundreds of thousands of patients across the U.S. are currently on a waiting list for a transplanted organ, and 20 people die each day waiting for a transplant. However, researchers within the Texas Medical Center…

Latest Press Releases

Pioneering biotech company reaches significant milestone well ahead of 6-8 month development time, successfully 3D bioprinting a human cardiac patch, as it seeks to produce full human hearts viable for transplant CHICAGO – June 25, 2018 – BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today…

Recent Blogs

Less than six months ago we announced our residency at the Johnson & Johnson Innovation JLABS at the renowned Texas Medical Center in Houston, Texas. Since that time, through the access of state-of-the-art equipment and support, we have been able to accelerate our scientific roadmap, successfully 3D bioprinting a human cardiac patch significantly ahead of schedule. Following…

Build a Heart. Save a life.

Invest Now

Bioprinter layering bio-ink of human heart cells

Scroll Up